Gelfand, Jeffrey M <br/><br/>
Ocrelizumab and Other CD20  [electronic resource] 

 -  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics  Oct 2017 
 - 835-841 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1878-7479 
<br/><br/><label>Standard No.: </label>10.1007/s13311-017-0557-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antigens, CD20--immunology<br/>B-Lymphocytes--drug effects<br/>Clinical Trials as Topic<br/>Disease Progression<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Multiple Sclerosis--drug therapy<br/>Treatment Outcome